Healthcare workers disinfect a stretcher after transporting a patient suffering from the Ebola virus disease from an ambulance at the Ebola Treatment Center in Bunia, Ituri, in the east of the DRC on June 23, 2026. [AFP]
Concerns are growing that delays in financing critical Ebola clinical trials could hamper efforts to contain the rapidly expanding outbreak in the Democratic Republic of Congo (DRC)
The Africa Centres for Disease Control and Prevention (Africa CDC) is warning that an urgent USD18 million funding gap is jeopardising key elements of the emergency response.
The warning comes days after global health partners unveiled an ambitious strategy aimed at ensuring vaccines and treatments for rare Ebola strains are developed before rather than during, future outbreaks.
Facts First
